Showing results (41-50 of 79) with videos related to
Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|October 8, 2019
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCEAlexandra K Lee, Mark Woodward, Dan Wang, et al.Journal of Epidemiology and Community Health|October 15, 2009
Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factorsAlison Beauchamp, Anna Peeters, Rory Wolfe, et al.Diabetes, Obesity & Metabolism|March 10, 2026
Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE StudyRuirui Wang, Yonghong Zhang, Yijie Gao, et al.European Heart Journal|March 14, 2009
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE studyXin Du, Toshiharu Ninomiya, Bastiaan de Galan, et al.Kidney International|June 11, 2022
Kidney omics in hypertension: from statistical associations to biological mechanisms and clinical applicationsMaciej Tomaszewski, Andrew P Morris, Joanna M M Howson, et al.Diabetes Care|March 1, 2014
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetesJuuso I Blomster, Sophia Zoungas, John Chalmers, et al.Kidney International Reports|February 22, 2021
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin ReceptorMegumi Oshima, Akinori Hara, Tadashi Toyama, et al.Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.Diabetologia|July 15, 2019
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON studyMegumi Oshima, Min Jun, Toshiaki Ohkuma, et al.Diabetologia|September 3, 2016
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetesJoep van der Leeuw, Frank L J Visseren, Mark Woodward, et al.Pageof 8